Related Experiment Video
Updated: Oct 15, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
[The clinical significance of non-traditional lipid parameters should be concerned]
1Cardiovascular Metabolic Center, FuWai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
Insights
Atherosclerotic cardiovascular disease (ASCVD) is a major global killer. Novel lipid indicators, beyond LDL-C, show promise in addressing residual ASCVD risk.
Area of Science:
- Cardiology
- Biochemistry
- Public Health
Background:
- Atherosclerotic cardiovascular disease (ASCVD) is the primary cause of global mortality.
- Dyslipidemia is a central factor in ASCVD development and progression.
- While low-density lipoprotein cholesterol (LDL-C) is a traditional target, residual risk persists.
Purpose of the Study:
- To review the current research on non-traditional lipid parameters.
- To explore novel lipid indicators associated with residual ASCVD risk.
Main Methods:
- Literature review of recent studies.
- Analysis of research on novel lipid indicators and cardiovascular risk.
Main Results:
- Emerging evidence links novel lipid parameters to residual ASCVD risk.
- These non-traditional markers offer potential for improved risk stratification.
Conclusions:
- Non-traditional lipid parameters are increasingly recognized for their role in ASCVD.
- Further research into these markers may refine cardiovascular disease management.
Abstract:
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of human deaths all over the world. Dyslipidemia is the central mechanism of the prevalence and development of ASCVD, which has been regarded as a remediable risk factor for cardiovascular disease. It's well known that the traditional lipid parameter, low-density lipoprotein cholesterol (LDL-C), is the primary target for lipid interfering in ASCVD. However, both randomized controlled trials and real-world studies have suggested that residual risk persists in spite of the well-controlled LDL-C levels according to current guidelines. Hence, in recent years, a series of studies have indicated that many novel lipid indicators are closely correlated with the residual risk of ASCVD. This article aimed to summarize the research status of these non-traditional lipid parameters in cardiovascular field.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test